SUDOSCAN is a medical device that offers a stimulation of the sweat glands that assess small nerve fibers
SUDOSCAN provides a better management of diabetes complications such as neuropathies to prevent diabetic foot.
SUDOSCAN has demonstrated its efficacy in painful neuropathies, transthyretin amyloidosis, Sjogren’s Syndrome, Hepatitis C, Fabry disease…
In oncology, SUDOSCAN has demonstrated its utility to quantify chemotherapy induced polyneuropathy (CIPN).
Clinical Evidence for SUDOSCAN
SUDOSCAN Is Becoming a Reference Test in Many Countries.
Commercialized worldwide with more than 5000 devices sold.
CE certified Cleared for use by the US FDA, Registered and distributed in 34 countries Included the European Network for TTR-FAP Amyloidosis, The German guidelines for Diabetes management, The Latin America Diabetes association, And more…
No patient preparation
Results in 3 minutes
Easy-to-read critical data points to help physicians reach a diagnosis
Easy to operate
CE and FDA approvals
Reproducible quantitative results
Independent from environmental conditions
Backed by evidence-based research
150 peer-reviewed journals publications